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Abstract
 
In the current study, we address the underlying mechanism for the selective generation of gut-
homing T cells in the gut-associated lymphoid tissues (GALT). We demonstrate that DCs in
the GALT are unique in their capacity to establish T cell gut tropism but in vivo only confer
this property to T cells in the presence of DC maturational stimuli, including toll-like receptor-
dependent and -independent adjuvants. Thus, DCs from mesenteric LNs (MLNs), but not
 
from spleen, supported expression of the chemokine receptor CCR9 and integrin 
 
 
 
4
 
 
 
7
 
 by
 
activated CD8
 
 
 
 T cells. While DCs were also required for an efficient down-regulation of
CD62L, this function was not restricted to MLN DCs. In an adoptive CD8
 
 
 
 T cell transfer
model, antigen-specific T cells entering the small intestinal epithelium were homogeneously
 
CCR9
 
 
 
 
 
4
 
 
 
7
 
 
 
CD62L
 
low
 
, and this phenotype was only generated in GALT and in the presence
of adjuvant. Consistent with the CCR9
 
 
 
 phenotype of the gut-homing T cells, CCR9 was
 
found to play a critical role in the localization of T cells to the small intestinal epithelium. Together,
these results demonstrate that GALT DCs and T cell expression of CCR9 play critical and
integrated roles during T cell homing to the gut.
Key words: lymphocytes • antigen-presenting cell • inﬂammation • chemokines • 
intestinal mucosa
 
Introduction
 
Whereas naive T cell migration is restricted to secondary
lymphoid organs, effector T cells have the ability to localize
to peripheral tissues such as the intestinal mucosa and in-
flamed skin. Effector T cell subsets display preferential
homing potential for different peripheral tissues, a process
that is mediated by the selective expression of cell adhesion
molecules and chemokine receptors (1). Effector T cells
homing to the intestine express high levels of the 
 
 
 
7
 
 inte-
grin 
 
 
 
4
 
 
 
7
 
, whose ligand MAdCAM-1 is expressed on post
capillary venules in the intestinal lamina propria (2), and
the chemokine receptor CCR9 (3), whose ligand CCL25
 
is selectively expressed by small intestinal epithelial cells (4, 5).
 
 
 
7
 
 integrins and CCL25 are important for T cell localization
 
to intestinal effector sites, since 
 
 
 
7
 
-deficient T cells are severely
impaired in their ability to localize to the intestinal mucosa,
and neutralizing antibodies to CCL25 partially block T cell
localization to the small intestinal epithelium (6, 7).
 
Recent data indicate that peripheral tissue-homing re-
ceptors are induced on T cells during their activation in
secondary lymphoid organs and that distinct secondary
lymphoid organ microenvironments underlie the genera-
tion of effector T cells with differential homing capacity
(7, 8). Thus, T cells activated in mesenteric LNs (MLNs)
 
express 
 
 
 
4
 
 
 
7
 
 and CCR9, whereas those undergoing acti-
 
vation in peripheral LNs (PLNs) are induced to express
P-selectin ligands. In addition, during the preparation of this
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article, Mora et. al. (9) reported that Peyer’s patch (PP)
 
DCs, but not splenic or PLN DCs, induce CD8
 
 
 
 T cells
to express 
 
 
 
4
 
 
 
7
 
 and to respond to the CCR9 ligand
CCL25. In the current study, we have examined the un-
derlying mechanism by which antigen driven T cell acti-
vation in MLN leads to the selective generation of intesti-
nal homing effector T cell populations.
 
Materials and Methods
 
Mice.
 
 OT-1 (provided by A. Mowat, University of Glas-
 
gow, Glasgow, UK), CCR9
 
 
 
/
 
 
 
 (10) and C57BL/6J-Ly5.1 mice
were bred and maintained at the Biomedical Center Animal Fa-
cility at Lund University. CCR9
 
 
 
/
 
 
 
 OT-I mice were obtained
 
by crossing OT-I 
 
 
 
 C57BL/6J (F7) CCR9
 
 
 
/
 
 
 
 litters with
C57BL/6J (F7) CCR9
 
 
 
/
 
 
 
 mice and screening the offspring by
flow cytometry and PCR. Ly5.2
 
 
 
Ly5.1
 
 
 
OT-1 mice were ob-
tained from OT-1 
 
 
 
 C57BL/6J-Ly5.1 matings.
 
Reagents.
 
OVA (grade VI; Sigma-Aldrich) was purified from
endotoxins by Detoxi-Gel™ (Pierce Chemical Co.) chromatog-
raphy. OVA
 
257–264
 
 peptide SIINFEKL was from Innovagen. LPS
(
 
Escherichia coli,
 
 serotype 055:B5) and polyinosine polycytidylic
acid (pI:C) were from Sigma-Aldrich. SNARF
 
®
 
-1 carboxylic
acid acetate succinimidyl ester (SNARF-1) and 5- and 6-car-
boxy-fluorescein diacetate succinimidyl ester (CFSE) were from
Molecular Probes. The chemokines CCL25 and CXCL10 were
from R&D Systems.
 
Purification of DCs, DC-depleted APCs, and OT-1 T Cells.
 
CD11c
 
 
 
 DCs were isolated using anti–CD11c-conjugated
MACS beads and LS columns (Miltenyi Biotech) according to
the manufacturer’s protocol. DC-depleted cells were obtained
by passing the CD11c
 
 
 
 fraction obtained after isolation of DCs
through a high magnetic field LD column (Miltenyi Biotech).
 
DC preparations were 
 
 
 
90% CD11c
 
 
 
 MHCII
 
 
 
, whereas DC-
depleted preparations contained 
 
 
 
0.2% CD11c
 
 
 
MHC II
 
 
 
 cells.
MLN DCs were also labeled with FITC-conjugated anti-
CD11c and PE-conjugated anti-CD8
 
 
 
 mAbs, and sorted into
APCs ( DC, n   3), or anti-CD3/CD28 mAbs (n   3–5). Gray and white bars represent APCs from MLN and spleen, respectively. (C) Percentages  
SD of OT-1 cells expressing indicated phenotype as a function of cell division (n   3). (D) Responsiveness of MLN DC (gray bars) and spleen DC
(white bars) stimulated OT-1 cells to CCL25 and CXCL10. One representative experiment is shown.
Figure 1. DCs from MLN, but not from spleen, are necessary and suf-
ficient to induce a CCR9  4 7
 CD62Llow phenotype on Ag-specific
CD8  T cells. CFSE-labeled OT-1 cells were stimulated with SIIN-
FEKL peptide-pulsed CD11c  DCs and CD11c  non-DCs or anti-
CD3/CD28 mAbs. After 4 d of culture, the fraction of responding OT-1
cells expressing CCR9, CD62L,  4 7, and CXCR3 was determined by
flow cytometry. (A) Representative results obtained for CCR9 and
CD62L. (B) Percentages   SD of responding OT-1 cells expressing indi-
cated phenotype after stimulation with DCs (DC, n   6), DC-depleted 
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CD11c
 
 
 
 CD8
 
 
 
 
 
 and CD11c
 
 
 
 CD8
 
 
 
 
 
 subsets using a FACS
 
®
 
Vantage cell sorter (BD Biosciences). Splenic CD8
 
 
 
 
 
 T cells
were obtained (
 
 
 
98% pure) from OT-1 mice using biotinylated
anti-CD8
 
 
 
 mAb followed by streptavidin-conjugated magnetic
beads according to standard MACS procedures (Miltenyi Bio-
tech).
 
In Vitro Cultures.
 
Purified APCs were pulsed at 
 
 
 
5 
 
 
 
 10
 
6
 
cells/ml with 1 nM SIINFEKL peptide for 2 h at 37
 
 
 
C. Peptide-
loaded APCs were extensively washed and used to stimulate
CFSE-labeled OT-1 cells (7) in flat bottom 96-well plates. Unless
stated, 10
 
5
 
 DCs/well or 5 
 
 
 
 10
 
5
 
 DC-depleted APCs/well were
used to stimulate 2 
 
 
 
 10
 
5
 
 OT-1 cells. OT-1 cells were also stim-
ulated with 10 
 
 
 
g/ml plate-adsorbed anti-CD3 mAb (145–2C11;
American Type Culture Collection) plus soluble anti-CD28 (1
 
 
 
g/ml; BD, PharMingen). Cells were cultured in complete me-
dium for 4 d and thereafter analyzed by flow cytometry.
 
Flow Cytometry Analysis.
 
Flow cytometry analysis was per-
formed as described previously (7). Specificity of the CCR9
staining was confirmed by preincubating the polyclonal rabbit
anti-CCR9 Ab (11) with 10 
 
 
 
g/ml of the corresponding anti-
genic peptide. Anti–mouse CXCR3 mAb (4C4; Millennium
Pharmaceuticals) was revealed by Cy5-conjugated goat anti–rat
IgM (
 
 
 
-chain specific; Jackson ImmunoResearch Laboratories).
All other mAbs were used as FITC, PE, or allophycocyanin con-
jugates (BD PharMingen).
 
Chemotaxis Assay.
 
OT-1 cells activated by spleen and MLN
DCs were labeled with 1 
 
 
 
M SNARF-1 and CFSE, respectively,
as previously described for CFSE labeling (7), mixed at a 1:1 ra-
tio, and their ability to migrate to optimal concentrations of
CCL25 (250 nM) or CXCL10 (100 nM) was determined in che-
motaxis assays (7). The number of SNARF-1
 
 
 
 (red fluorescence)
and CFSE
 
 
 
 (green fluorescence) cells in the starting population
(cells
 
start
 
) and in the population migrating to chemokine
(cells
 
chemokine
 
) or medium alone (cells
 
medium
 
) was determined by
flow cytometry analysis. Specific migration is expressed for
SNARF-1
 
 
 
 cells (primed by spleen DCs) and CFSE
 
 
 
 cells
(primed by MLN DCs) as 100 
 
 
 
 [number of cells
 
chemokine
 
 
 
 
 
number of cells
 
medium
 
] / number of cells
 
start
 
.
Adoptive Transfer Experiments. CD8   OT-1 cells (3–5  
106) were injected i.v. into C57BL/6J-Ly5.1 mice, and 1–2 d
later recipient mice received an i.p. injection of 200  l PBS con-
taining 5 mg OVA with or without 100  g pI:C or 100  g LPS,
or 2.5 mg alum-precipitated OVA. 2–3-d later, mice were killed,
and organs were collected after perfusion of lung with  5 ml
PBS. Isolation of small intestinal intraepithelial lymphocytes
(IELs) and lymphocytes from LNs, spleen and lung was per-
formed as previously described (7).
Results
Dendritic Cells from MLN, but Not from Spleen, Are Neces-
sary and Sufficient for Antigen-dependent Generation of  4 7
 ,
CCR9 , and CD62Llow CD8  T Cells In Vitro. The se-
lective generation of CCR9  (7) and  4 7
  (8) T cells in
the MLN during in vivo primary immune responses sug-
gests that APCs residing in the intestinal tissues are func-
tionally distinct from APCs present in nonintestinal sites.
To address this point, we stimulated OVA-specific TCR
transgenic CD8  T (OT-1) cells in vitro with OVA pep-
tide-loaded DCs from MLN and spleen, respectively.
Since naive murine CD8  T cells express CCR9 (7, 11),
we labeled the purified OT-1 cells with CFSE before cul-
ture to enable analysis of responding T cells only. When
cultured with MLN DCs for 4 d, 39   3% (mean value  
SD, n   6) of responding OT-1 cells expressed CCR9
(Fig. 1, A and B). Parallel cultures with spleen DCs gave
rise to only 2.9   0.9% (n   6) CCR9  cells among re-
sponding T cells. In agreement with a recent report, ex-
pression of  4 7 was also selectively induced by MLN
DCs (Fig. 1 B) (12). OT-1 cells stimulated with anti-CD3
plus anti-CD28 mAbs were CCR9  4 7
 . Similarly, T
cells responding to peptide-loaded, DC-depleted APCs
from MLN were CCR9 , and compared with MLN DCs
these DC-depleted APCs were also poor in supporting T
cell expression of  4 7 (Fig. 1, B and C). In contrast, DC
and DC-depleted APCs from both MLN and spleen were
potent inducers of CXCR3 on OT-1 cells (Fig. 1, B and
C). Finally, OT-1 cells activated by MLN DCs, but not
by spleen DCs, migrated to CCL25, whereas both popu-
lations migrated to the CXCR3 ligand CXCL10 (Fig. 1
D). Together these results demonstrate an explicit re-
quirement for gut-associated lymphoid tissue (GALT)
DCs in the generation of CCR9  4 7
 CD8  effector T
cells.
We also investigated the role of APC in the down-regu-
lation of CD62L on OT-1 cells. Both MLN and spleen
DC populations efficiently induced a CD62Llow pheno-
type on activated OT-1 cells, a regulatory property not
shared by DC-depleted APCs from MLN or spleen (Fig.
1, A and B). This was not due to differences in cell cycle
progression, since OT-1 cells that had undergone a large
number of divisions in the absence of DCs maintained
high levels of CD62L expression (Fig. 1 C). Thus, al-
though DCs are also required to support an efficient loss of
Figure 2. MLN CD8   and CD8   DC subsets regulate OT-1 cell
expression of CCR9,  4 7, and CD62L in a similar manner. CFSE-labeled
OT-1 cells (105) were stimulated for 4 d with Ag-pulsed CD8   and
CD8   DC subsets from MLN (5   104 of each) or by anti-CD3/CD28
mAbs, and CCR9,  4 7, and CD62L were analyzed by flow cytometry.
The percentage of responding OT-1 cells expressing a CCR9 ,  4 7
 , or
a CD62Llow phenotype is indicated for each analysis.Intestinal Dendritic Cells Regulate T Cell Tropism for the Gut 966
CD62L on OT-1 cells, this capacity is not restricted to
GALT DCs.
Both CD8   and CD8   MLN DC Support the Antigen-
dependent Generation of CCR9  4 7
 CD62L  T Cells.
DCs can be divided into discrete subsets based on pheno-
typic and functional differences. Since the relative number
of these DC subsets differs in various lymphoid organs, the
selective capacity of MLN DCs to induce CCR9 and  4 7
could potentially reflect differences in DC subset composi-
tion in MLN and spleen, respectively. Therefore, we acti-
vated CFSE-labeled OT-1 cells with peptide-loaded
CD8   and CD8   MLN DCs, respectively. OT-1 cells
stimulated by both DC subsets expressed CCR9 and  4 7
and down-regulated CD62L (Fig. 2). Thus, the selective
capacity of DCs in the MLN to instruct T cells to express
CCR9 and  4 7 is not related to a prevalence of a particu-
lar DC subset in this lymphoid organ.
In Vivo Gut-homing CD8  T Lymphocytes Selectively Arise
in the GALT and Are Efficiently Generated Only in the Presence
of Adjuvant. Next, we performed OT-1 cell adoptive
transfer experiments to investigate the nature of, and re-
quirements for, the in vivo differentiation of gut-homing
CD8  T cells. In this transfer model, OT-1 cells start to
proliferate  24 h after immunization, are retained within
the lymphoid organ for up to  48 h, and start to appear in
the peripheral tissues 3-d postimmunization (not depicted
and reference 7). To enable identification of the donor cells,
Ly5.2  OT-1 cells were adoptively transferred to C57BL/
6J-Ly5.1 recipient mice, and the phenotype of Ly5.2  do-
nor cells in the PLN, MLN, spleen, lung, and the IEL com-
partment was analyzed by flow cytometry 3 d after i.p. im-
munization with OVA plus pI:C. The majority of OT-1
cells in MLN, but not PLN or spleen, expressed CCR9 and
 4 7 (Fig. 3 A). In all of these lymphoid organs, OT-1 cells
Figure 3. In vivo gut-homing OT-1 cells express a CCR9  4 7
 CD62Llow phenotype which is induced efficiently only in GALT and after adjuvant-
triggered inflammation. OT-1 cells were injected i.v. into C57BL/6J-Ly5.1 mice, and 2 d later mice received OVA i.p., either alone or in combination
with adjuvant. (A) Flow cytometry analysis of OT-1 cells in indicated organs 3 d after immunization with OVA and pI:C. (B) Phenotype of OT-1 cells
in the MLN and IEL compartment 3 d after immunization with OVA alone or OVA with adjuvant. (C) CFSE-labeled OT-1 cells were transferred into
C57BL/6J-Ly5.1 mice, and donor cells in MLN and spleen were analyzed by flow cytometry 2 d after immunization with OVA or OVA plus pI:C.
Results are representative of two to three performed experiments.Johansson-Lindbom et al. Brief Definitive Report 967
had acquired expression of CXCR3 (not depicted) and
down-regulated CD62L, indicating a similar degree of acti-
vation in these tissues. OT-1 cells that had migrated to the
IEL compartment displayed a highly homogenous pheno-
type, expressing  4 7 and CCR9 but not CD62L. In con-
trast, OT-1 cells accumulating in the lung were a more
heterogeneous population that appeared to phenotypically
reflect OT-1 cells generated in both MLN, PLN, and
spleen (Fig. 3 A). Thus, during an ongoing systemic im-
mune response, MLN, but not PLN or spleen, support the
differentiation of Ag-specific CD8  T cells into activated
cells, displaying the phenotypic signature of CD8  T cells
migrating into the small intestinal epithelium.
Since DCs tend to undergo maturation during isolation
procedures, we investigated the in vivo requirements for
adjuvant in the regulation of these homing receptors. OT-1
recipient mice were immunized i.p. with either OVA
alone or in combination with LPS, pI:C, or alum. Whereas
LPS and pI:C represent toll-like receptor (TLR)–depen-
dent adjuvants (TLR4 and TLR3, respectively), the in-
flammatory response elicited by alum is TLR independent
(13). Irrespective of the adjuvant used, a large number
OT-1 cells in MLN 3 d after immunization were
CCR9  4 7
 CD62L  (Fig. 3 B). In mice receiving OVA
alone, the majority of OT-1 cells in MLN maintained ex-
pression of CD62L and were CCR9 . The fraction of
 4 7
  OT-1 cells was also relatively low compared with
mice receiving OVA in the presence of adjuvant. In con-
trast, adjuvant was not required for induction of CXCR3
(not depicted). To rule out the possibility that the adju-
vant-dependent regulation of CCR9,  4 7, and CD62L
reflected increased cell division of OT-1 cells in the pres-
ence of adjuvant, CFSE-labeled OT-1 cells were trans-
ferred into recipient mice, and their expression of CD62L
and intensity of CFSE fluorescence were determined 2 d
after immunization. Both in the presence of pI:C and in
the absence of adjuvant, the majority of OT-1 cells had un-
dergone four to five cell divisions; however, only immuni-
zation with adjuvant supported efficient cell cycle–depen-
dent down-regulation of CD62L (Fig. 3 C). Finally,
irrespective of immunization strategy being employed,
OT-1 cells migrating to the small intestinal epithelium ex-
pressed CCR9 and  4 7 and had down-regulated CD62L
(Fig. 3 B). These results demonstrate that the in vivo acqui-
sition of a gut-homing phenotype on Ag-activated CD8 
T cells is restricted to the GALT and is highly dependent
on the presence of adjuvants.
OT-1 Lymphocyte Localization to the Small Intestinal Epi-
thelium After Immunization with OVA and Adjuvant Is CCR9
Dependent. To determine the importance of CCR9 in the
localization of recently activated CD8  T cells to the small
intestinal epithelium during an Ag plus adjuvant-driven
immune response, CCR9 / OT-1 (Ly5.2 ) cells (see Ma-
terials and Methods) were coinjected with WT OT-1
(Ly5.1 Ly5.2 ) cells into C57BL/6J-Ly5.1 recipient mice,
and the percentage of each population in the MLN, lung,
and small intestine was determined 3 d after immunization
with OVA and LPS. As shown in Fig. 4, the CCR9 /  to
WT OT-1 cell ratio in the MLN and lung remained similar
to the input ratio. In marked contrast, the CCR9 /  to
WT OT-1 cell ratio in the small intestinal epithelium was
reduced  10-fold compared with the input ratio (Fig. 4, B
and C). Thus, CCR9 plays a critical and selective role in
CD8  T cell localization to the small intestinal epithelium.
The role of CCR9 was far greater than that implied from
previous studies using neutralizing anti-CCL25 antibody
(7), potentially due to an inability of the antibody to fully
neutralize epithelial-derived CCL25 in vivo.
Discussion
In the course of DC–T cell interactions, DCs have
proven instrumental in shaping the magnitude and nature
of the induced adaptive response. For example, DCs are
involved in the regulation of immunogenic versus tolero-
genic responses and in the development of CD4  Th1
versus Th2-associated immunity (14). In the present
study, we demonstrate an additional and central role for
DCs in the generation of tissue tropic effector T lympho-
cyte subsets. Our results reveal that DCs (but not other
APCs) residing in the MLN, but not in spleen, directly
support the generation of Ag-responding T cells express-
ing a CCR9   4 7
  phenotype, identical to that of T
cells entering into the small intestinal epithelium. Since
DCs in PP were also recently shown to imprint expression
Figure 4. OT-1 lymphocyte localization to the small intestinal epithe-
lium after immunization with OVA and adjuvant is CCR9 depen-
dent.  CCR9 /  (Ly5.1 Ly5.2 ) and WT (Ly5.1 Ly5.2 ) OT-1 cells
were coinjected (3–5   106 total cells) i.v. into C57BL/6J-Ly5.1
(Ly5.1 Ly5.2 ) mice. Mice received OVA and LPS i.p. 2 d after cell
transfer, and the percentage of CCR9 /  and WT OT-1 cells among
CD8  T cells was determined in each organ by flow cytometry analysis
3 d later. (A and B) Representative flow cytometry analysis from one ex-
periment of three performed. (C). The CCR9 /  to WT OT-1 cell ratio
in the MLN and IEL. Organ ratio was determined by dividing the per-
centage of CCR9 /  (Ly5.2 ) OT-1 cells with the percentage of WT
(Ly5.1 Ly5.2 ) OT-1 cells in each organ. Results are mean (SEM) of four
mice in each group and from one representative experiment of three per-
formed. *P   0.0286. Dotted line represents the CCR9 /  to WT OT-1
cell input ratio.Intestinal Dendritic Cells Regulate T Cell Tropism for the Gut 968
of  4 7 and responsiveness to CCL25 among responding
T cells (9), it appears that GALT DCs share a capacity to
induce a gut-homing phenotype on effector T cell popu-
lations. Differences in DC subset composition in GALT,
compared with other secondary lymphoid organs, are un-
likely to account for this capacity, since both CD8   and
CD8   DCs in MLN were able to support T cell expres-
sion of CCR9 and  4 7. Rather, since immature PP DCs
are in close proximity to the intestinal surface (15), and
MLN DCs are thought to derive from the intestinal mu-
cosa, it seems likely that the intestinal mucosal microenvi-
ronment is conferring on intestinal DCs the ability to gen-
erate gut-homing T cell populations. Our results also
demonstrate a critical role for DCs in down-regulating
CD62L on responding T cells. Thus, DCs appear to play a
dual role in the generation of gut-homing T cell popula-
tions, first in providing GALT-specific signals, leading to
the generation of CCR9  4 7   T cells, and second in a
nontissue selective manner, by down-regulating CD62L
and thus preventing T cell reentry into secondary lym-
phoid organs (16).
We also demonstrated that an efficient generation of gut
tropic T cells in vivo requires adjuvant. Adjuvants are potent
in inducing DC maturation, and although DCs can support
initial T cell activation after immunization with protein Ags
only, such a response is driven by immature DCs, as evi-
denced by a tolerogenic rather than an immunogenic out-
come (17). Hence, our results indicate that only mature DCs
can support the generation of gut-homing T cells in vivo
and are in agreement with previous reports demonstrating
an important role for CD40 (18) and CD80/CD86 (19) for
CD8  T cells localization to the intestinal epithelium, as
these costimulatory molecules are expressed at high levels
only by mature DCs (14). However, since engagement of
CD40L by CD40 and CD28 by CD80/CD86 is not con-
fined to the GALT, other molecular interactions must oper-
ate in parallel or in a sequential manner in order to drive the
GALT-selective generation of gut tropic T cells. Such se-
quential cross-regulation by DCs and T cells operates, for
example, during the adjuvant-dependent differentiation of
naive CD4  T cells into CXCR5  follicular helper T cells
(20). A few OT-1 cells expressing a gut tropic phenotype
were also generated after immunization with OVA alone,
and cells localizing to the small intestinal epithelium under
these conditions were invariably CCR9  4 7
 CD62L ,
suggesting that there may be low grade homeostatic inflam-
mation in GALT, potentially driven by adjuvants provided
by the enteric microflora. However, the efficient generation
of gut tropic T cells in the presence of adjuvant indicates that
the majority of T cells within the normal intestinal mucosa
are specific to Ag that has been presented in the context of
an inflammatory response.
In conclusion, the current study provides several impor-
tant insights into the generation of the intestinal T cell
compartment and intestinal acquired immune responses.
First, we provide compelling evidence for the importance
of GALT DCs in the generation of gut tropic T cells; sec-
ond, we demonstrate a requirement for adjuvant for the ef-
ficient DC-dependent generation of gut tropic T cells and
finally we show, to our knowledge, the first direct evidence
for a role of CCR9 in T cell localization to the small intes-
tinal epithelium. Together, these results suggest that target-
ing GALT DCs and CCR9 will provide a mechanism for
modulating the generation of gut tropic T cells and T cell
entry to the intestinal mucosa, respectively—physiological
processes highly relevant to the development of mucosal
vaccines and treatment of inflammatory bowel disease.
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